FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COLCRYS (colchicine) submitted by Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Familial Mediterranean Fever
• Gout
• Pericarditis

Drugs mentioned

• COLCRYS (COLCHICINE)

Snippet

SUPPL AP for COLCRYS (COLCHICINE)